Thomas A. DYSPNEA
awareness
is an uncomfortable of the act of breathing, leading to a sensation most conveniently described as breathlessness. It may arise as a result of numerous mechanisms.1,2 However, in both cardiac and pulmonary disease, the most common cause is disordered lung
airways obstruction
dyspnea. Hyperinflated lungs, prolonged expiration, a small heart, and the bedside and laboratory evidence of
mechanics. The two major forms of disordered lung mechanics that result in pulmonary dyspnea are obstructive lung diseases, causing increased airway resistance, and restrictive lung diseases, causing increased lung stiffness. In patients with cardiac dyspnea, the major cause of dyspnea also is increased lung stiffness, leading to a type of restrictive lung disease. As a result, patients with dyspnea purely related to obstructive lung disease seldom pose a problem in the separation of cardiac and pulmonary
of restrictive lung disease? Aside from the obvious, namely that restrictive disease in the presence of heart disease usually means cardiac dyspnea and without heart disease means pulmonary disease, the most reliable approach is a therapeutic trial with diuretics. In cardiac dyspnea, the loss of excess lung water will often lead to a rapid resolution of the physiologic, roentgenographic, and clinical abnor malities. In pulmonary dyspnea, this
causes
This article is one of a series sponsored by the American Heart Association, edited by Richard L. Popp, MD. From the Stanford University School of Medicine and Medical Center, Stanford, Calif. Reprint requests to Stanford University School of Medicine and Medical Center, Stanford, CA 94305 (Dr Raffin).
There are a number of circumstances in which this simplistic approach is not adequate. Cardiac asthma (recurrent episodes of bronchoconstrietion asso ciated with pulmonary edema) can usually be distinguished from bron chial asthma by the existence of left ventricular disease, by the absence of eosinophilia, and by elimination of the bronchial constrictive episodes by ap propriate diuresis. Dyspnea with both cardiac and pulmonary components is often diffi cult or impossible to separate into component parts. Here again, the empirical use of diuretics may be help ful. Clinical abnormalities still present after adequate treatment of the cardiac component usually can be attributed to underlying pulmonary disease. In pa tients who are either undergoing
cardiac catheterization or are critically ill in an intensive care unit, the finding of an elevated pulmonary capillary wedge pressure points toward a prob able cardiac component. However, as before, determining whether or not the cardiac component is playing an impor tant clinical role is based on a carefully controlled trial of diuretics. The dyspnea related to intrinsic pulmonary vascular disease is particu larly difficult to diagnose. Its patho genesis is not clear. It may be seen without mechanical abnormalities of the lung and in the absence of other abnormalities of pulmonary function (normal blood gas values). The second ary cardiac disturbances may be so subtle that they are difficult to detect early in the disease. Possibly, the best approach is to consider the possibility of primary pulmonary vascular disease in patients whose mechanical abnor malities of lung function and hemodynamic abnormalities are insufficient to explain the existence of continued and
disease produce similar abnormalities. The differences that are present involve a difference in pathogenetic mechanism and the fact that the functional abnormalities are usual ly more easily reversed in cardiac as compared to pulmonary dyspnea. Blood gas measurements are not useful in differential diagnosis because abnor malities of blood gases, such as hypoxemia, play little or no role in clinical dyspnea, and also because identical changes in blood gases occur in both forms of dyspnea. Occasionally, mea surements of pulmonary wedge pres sures may indicate the existence of subtle forms of heart disease causing increased pulmonary capillary pres sure. Measurements of pulmonary ar tery pressure may be useful in identify ing patients with dyspnea related to pulmonary vascular disease. Newer techniques for noninvasively estimat
primary lung
progressive dyspnea.
ing pulmonary capillary wedge pres sure and for total lung water are still in the developmental and testing
stage.
Conclusions
Since the abnormalities of lung function and the neurophysiological basis of dyspnea are identical, the separation is often difficult. The ability to rapidly reverse the physiologic abnormalities with diuretics in cardiac dyspnea is of major assistance. Pa tients with both lung and heart disease are particularly difficult to separate. Diuresis is particularly helpful in such patients. The dyspnea associated with primary pulmonary vascular disease is poorly understood. This possibility should be considered in patients with pulmonary mechanical abnormalities that do not seem adequate to explain the degree of dyspnea. Hemodynamic measurements may be useful in pa tients with subtle forms of heart disease or with pulmonary vascular dyspnea. Separating the two forms of dyspnea may be extraordinarily diffi cult in some patients. This investigation was supported in part by
eases.
What is the role of special measure ments in the differential diagnosis of cardiac vs pulmonary dyspnea?4 Mea surements of pulmonary function are helpful only to demonstrate the exis tence of obstructive lung disease. Given a restrictive mechanical defect, then both primary cardiac disease and
Dyspnea associated with chronic lung disease is usually easily distinguished from cardiac dysp nea. Stiff lungs are the usual cause of both cardiac dyspnea and the dyspnea associated with restrictive lung disobstructive
pulmonary dyspnea. Circulation 7:15-29, 1953. 2. Rapaport E: Dyspnea: Pathophysiology and differential diagnosis. Prog Cardiovasc Dis
13:532-545, 1975. 3. Robin ED, Cross CE, Zelis R: Pulmonary edema. N Eng J Med 288:239-246, 292-304, 1973. 4. Kettel LJ, Moran F, Cugell DW: Pulmonary
New
Requirement
for Authors
Congress recently passed The Copyright Revision Act of 1976, effective January 1,1978, which affects the American Medical Association's procedure for reviewing manuscripts submitted for publication. In view of this law, all transmittal letters accompanying manuscripts should contain the following language: "In consideration of the AMA taking action in reviewing and editing my (our) submission, the author(s) undersigned hereby transfers, assigns, or otherwise conveys all copyright ownership to AMA in the event that such work is published by the
AMA."